1. Syncope …
The Right Test for
the Right Patient
(Osama Alhadramy MD, FRCP(C
*
Engel GL. 7th century
2. Objectives
Who should be admitted?
Who should admit/see the patient in the
ER ?(getting the right consult(
What is the right test for your patient?
Cases
3. 76y M with high lipids ,HTN (HCT 4 /12(
Recurrent exersional syncope q 4 days for 2/12
Seen by GP , D/C HCT for postural hypotension
without improvement .
Exersional SOB for 2 y class I-III
Nausea and Diarrhea for 2 weeks
Multiple injuries
O/E Obese , no CHF, no murmer
4.
5. 84 y M with no health issues
First episode witnessed syncope
Minimal CP on exertion for months
O/E B9, no murmurs
-ve CK / Trop
6.
7.
8. ?Are we doing good job
WHO**
Statistical Information System**
9. Definition
Syncope is a transient loss of
consciousness, associated with loss of
postural tone, with :
1. spontaneous return to baseline
neurologic function
2. requiring no resuscitative efforts .
*AHA/ACCF Scientific Statement on the Evaluation of Syncope
J Am Coll Cardiol 2006;47:473– 84.
*EHA statement 2004
10. Impact of Syncope
100%
73% 1 71% 2
80%
Proportion of Patients
60% 2
60%
37% 2
40%
20%
0%
Anxiety/ Alter Daily Restricted Change
Depression Activities Driving Employment
Linzer, J Clin Epidemiol, 1991.
1
Linzer, J Gen Int Med, 1994.
2
11. Syncope: Etiology
Structural Non-
Neurally- Cardiac
Orthostatic Cardio- Cardio-
Mediated Arrhythmia
Pulmonary vascular
1 2 3 4 5
• Vasovagal • Drug • Brady • Aortic • Psychogenic
• Carotid Induced Sick sinus Stenosis
AV block • Metabolic
Sinus • ANS • HOCM
• Tachy e.g. hyper-
• Situational Failure • Pulmonary
Cough Primary VT* ventilation
SVT Hypertension
Post- Secondary
• Long QT • PE
micturition
Syndrome
Unknown Cause
DG Benditt, UM Cardiac Arrhythmia Center
14. Famous MCQ in medicine
…….. is the best tool to diagnose syncope
and to determine the etiology .
EPS
History /Physical
ILR
HM
Telemetry
King's of Heart
CT
EEG
15. How good is H/P
15 June 1997 • Annals of Internal Medicine
17. Associated symptoms
Neurally-mediated syncope:
1. Absence of cardiac disease
2. Long history of syncope
(Chronic presentation(
3. After unpleasant sight, sound, smell or pain
4. Prolonged standing or crowded, hot places
5. Nausea, vomiting associated with syncope
6. With head rotation, pressure on carotid sinus
(as in tumors, shaving, tight collars(
18. Syncope due to orthostatic hypotension:
1. After standing up
2. Temporal relationship with start of
medication leading to hypotension or
changes of dosage
3. Presence of autonomic neuropathy or
Parkinsonism
19. Things suggestive of seizure
Prodrome (aura)
Episode of abrupt onset associated with injury
Presence of a tonic phase before the onset of rhythmic clonic
activity
Head deviation or unusual posturing during the episode
Tongue biting (particularly involving the lateral aspect of the
tongue)
Loss of bladder or bowel control
Prolonged postictal phase during which the patient is confused
and disoriented.
.J Am Coll Cardiol 2002 Jul 3;40(1):142-8
24. Absence of Pre-syncope
The sudden loss of consciousness without
warning (pre-syncope( is most likely to
result from an arrhythmia (bradycardia or
tachycardia(.
26. Duration of symptoms
A prolonged loss of consciousness may
indicate a seizure or aortic stenosis.
By comparison, arrhythmias and
neurocardiogenic syncope are often
associated with a brief period of syncope,
since the supine position reestablishes
some blood flow to the brain and can
therefore result in the restoration of
consciousness
27. Recovery
Persistence of nausea, pallor, and
diaphoresis in addition to a prolonged
recovery from the episode suggest a vagal
event.
Significant neurologic changes or
confusion during the recovery period may
be due to a stroke or seizure.
34. Holter Monitor
Class I
1. patients who have the clinical or ECG
features suggesting an arrhythmic cause
of syncope.
2. Patients with very frequent syncopes
36. Series of 95 patients with syncope
1. 1st HM 14/95 (15%(
2. 2nd HM 9/ 81 (11%(
3. 3rd HM 3 /72 (4.2%(
Arch Intern Med. 1990 May;150(5):1073-8
37. Predictors of abnormal HM
1. age above 65 years
2. history of heart disease
3. initial none sinus rhythm
Arch Intern Med. 1990 May;150(5):1073-8
38. (Event recorders (King's of heart
Yield 20% *
often do not provide useful information
since the patient must be conscious in
order to activate the unit and "store" the
rhythm at the time of the symptom .
.Krahn, Cardiology Clinics, 1997*
39. Implantable loop recorder
Yield 65-90% **
(ILR( is a subcutaneous monitoring device
for the detection of cardiac arrhythmias.
It stores recorded ECG strips either when
the device is activated automatically
according to programmed criteria or when
the patient manually activates it with
magnet application
Krahn, Circulation, 1995*
Krahn, Cardiology Clinics, 1997*
41. 56 y woman with syncope
accompanied with seizures.
AV Block
65 yo man with syncope.
VT and VF
42. RAST trial
Unexplained Syncope
n=60
ILR Conventional
n=30 n=30
In Follow-up Diagnosed Undiagnosed Diagnosed Undiagnosed
n=3 n=14 n=13 n=6 n=24
Krahn A, Klein GJ, Skanes Y. Circulation 2001; 104:46-51.
43. RAST Crossover Results
Unexplained Syncope
n=60
13/30 24/30
Undiagnosed after monitoring Undiagnosed after conventional
6 accepted crossover to conventional 21 accepted crossover to ILR
Diagnosed Undiagnosed Diagnosed Undiagnosed In follow-up
n=1 n=5 n=8 n=5 n=8
Krahn A, Klein GJ, Skanes Y. Circulation 2001; 104:46-51.
44. RAST - Diagnoses
14
12
number of patients
10
ILR Conventional
8
6
4
2
0
Bradycardia Tachycardia Vasovagal Seizures
Krahn A, Klein GJ, Skanes Y. Circulation 2001; 104:46-51.
45. Class I
1. When the mechanism of syncope
remains unclear after conventional work
up.
2. Patients who have the clinical or ECG
features suggesting an arrhythmic
syncope
3. History of recurrent syncope with injury.
47. No need for any monitoring
Class III (ECG monitoring is unlikely to
be useful( :
1. Do not have the clinical or ECG features
suggesting an arrhythmic or structural
heart disease
2. No recurrent syncope( single episode(
49. Class I
ECG monitoring excludes an arrhythmic
cause when there is a correlation between
syncope and no rhythm variation
50. Echocardiography
Diagnoses of underlying structural heart
disease such as left ventricular
dysfunction, hypertrophic cardiomyopathy,
or significant aortic stenosis .
Yield 0-20%
52. CONCLUSIONS:
Echocardiography was most useful for
assessing the severity of the underlying
cardiac disease and for risk stratification in
patients with unexplained syncope but
with a positive cardiac history or an
abnormal ECG
53. Class I
ECHO is recommended if suspect
structural or coronary heart disease.
54. Upright tilt table test
Very useful in young, and healthy patients
in whom the diagnosis of
neurocardiogenic syncope is suspected .
Yield 11-90% ***
*PACE, Vol. 20 April 1997, Part I 875
*Kapoor, JAMA, 1992
55. Diagnosing VVS
(ACC Consensus Protocol(
Overnight fast
ECG
Blood pressure
Supine least 5 -20 min
Tilt minimum of 20 min and a 60° 80°
maximum of 45 min
57. Class I
1. Unexplained single syncopal episodes in
high risk settings
2. Recurrent episodes in the absence of
organic heart disease
3. In the presence of organic heart disease,
after cardiac causes of syncope have
been excluded.
58. Coronary angiogram / stress testing
Class I
1. In patients with syncope suspected to be
due to myocardial ischemia.
2. Patients with syncope and risk factors for
CAD and symptoms of angina or angina
equivalent.
3. Syncope related to exersice
59. Electrophysiology study
Patients who may benefit from an EP
study include those with:
1. Left ventricular dysfunction
2. Significant coronary artery disease
3. A prior myocardial infarction
4. Other structural heart disease
5. Conduction system disease (eg, bundle
branch block(
Yield 50%
Stetson P, et al. PACE. 1999; 22 (part II): 782
60. Class I
1. Abnormal electrocardiography
2. Structural heart disease
3. syncope associated with palpitations or
family history of sudden death
65. BNP
148 patients with syncope
THE AMERICAN JOURNAL OF CARDIOLOGY VOL. 93 JANUARY 15, 2004
66. ?Who should be admitted
Abnormal ECG
History of cardiac disease, chest pain or heart
failure
Persistently low blood pressure (systolic <90
mmHg(
Exersional SOB or angina
Hematocrit <30 (if obtained(
Older age >60
Family history of sudden cardiac death
Ann Emerg Med. 2007 Apr;49(4):431-44
Am J Emerg Med. 2005 Oct;23(6):782-6
70. Conventional Diagnostic Methods/Yield
Test/Procedure Yield
History and Physical 49-85% 1, 2
(including carotid sinus massage(
ECG 2-11% 2
Electrophysiology Study without SHD* 11% 3
Electrophysiology Study with SHD 49% 3
Tilt Table Test (without SHD) 11-87% 4, 5
Ambulatory ECG Monitors:
• Holter 2% 7
• External Loop Recorder 20% 7
(2-3 weeks duration(
• Insertable Loop Recorder 65-88% 6, 7
(up to 14 months duration(
Neurological †
(Head CT Scan, Carotid Doppler( 0-4% 4,5,8,9,10
1
Kapoor, et al N Eng J Med, 1983. 5
Kapoor, JAMA, 1992 9
Day S, et al. Am J Med. 1982; 73: 15-23.
2
Kapoor, Am J Med, 1991. 6
Krahn, Circulation, 1995 10
Stetson P, et al. PACE. 1999; 22 (part II(: 782. * Structural Heart Disease
3
Linzer, et al. Ann Int. Med, 1997. 7
Krahn, Cardiology Clinics, 1997.
8
Eagle K,, et al. The Yale J Biol and Medicine. 1983; 56: 1-8.
†
MRI not studied
4
Kapoor, Medicine, 1990.
71. Bottom line
In young patients without suspicion of
heart or neurological disease and
recurrent syncope , tilt testing should be
done first.
Older patients, carotid sinus massage is
recommended as first step.
Patients with evidence of structural heart
disease from H&P , palpitation,
extensional symptoms cardiac work up
should be done first .
73. 76y M with high lipids ,HTN (HCT 4 /12(
Recurrent syncope q 4 days for 2/12
Seen by GP , D/C HCT for postural
hypotension without improvement .
Exersional SOB for 2 y class II
Nausea and Diarrhea for 2 weeks
Multiple injuries
O/E Obese , no CHF, no murmer
74.
75. Telemetry : no arrhythmia
ECHO:EF 40% with segmental RWMA,
mild AV sclerosis
MIBI: High risk Circ ischemia , EF 45%
76.
77. 84 y M with no health issues
First episode witnessed syncope
Minimal CP on exertion for months
O/E B9, no murmurs
-ve CK / Trop
78.
79. EP : Pace maker
ECHO: EF 45-50% with DD
D/C home
10 days later came with syncope / fall
New ant T changes with Trop 23 , no CP
Impact of Syncope Syncope result in substantial cost to patients and to society. For example, syncope patients live with lifestyle altering restrictions that affect daily activities, mobility, and employment. In addition, syncope and falling in the elderly commonly cause injury, institutionalization and premature death. Falls directly or indirectly cause 12% of deaths in geriatric population. (Baraff 1997 ). ____________________ Linzer M, Pontinen M, Gold DT, et al. Impairment of physical and psychological function in recurrent syncope. J Clin Epidemiol. 1991;44:1037-1043 . Linzer M, Gold DT, Pontinen M, et al. Recurrent syncope as a chronic disease: Preliminary validation of a disease-specific measure of functional impairment. J Gen Int Med. 1994;9:181-186 .
This slide provides a simple classification of the principal causes of syncope. This scheme lists the causes of syncope from the most commonly observed (Left) to the least common (Right). This ranking may be helpful in thinking about the strategy for evaluating syncope in individual patients . Within the boxes,the most common causes of syncope are indicated for each of the major diagnostic groups. The numbers at the bottom of each column provide an approximate value for the average frequency (Kapoor 1998) with which that category appears in published reports summarizing diagnostic findings. It should be noted that orthostatic causes are not often referred to specialists and consequently tend to be under represented in the literature .
The Reveal ® Plus Insertable Loop Recorder system offers long-term, continuous, subcutaneous ECG monitoring and event-specific recording. This implantable device is designed to improve patient compliance with long-term AECG monitoring . The system includes an implanted loop recorder, a hand-held patient Activator, and a programmer with telemetry head that communicates noninvasively with the implanted device . When a patient experiences an episode, the device stores an ECG using the Activator or through the use of a auto-activating feature . The Reveal ® Plus ILR can monitor continuously for up to 14 months. The probability of capturing an event is high—approximately 65-88%. 1,2 The ECG captured during the episode may “reveal” the ECG during the patient’s episode or may allow the clinician to rule in or rule out arrhythmic causes . The stored ECG data is retrieved, viewed, and printed or saved to a disk, using a Medtronic 9790 programmer with a 9766 A or AL programmer head . The Reveal ILR can then be re-started for continued monitoring . 1 . Krahn A, et al. Final results from a pilot study with an insertable loop recorder to determine the etiology of syncope in patients with negative noninvasive and invasive testing. Am J Cardiol, 1998;82:117-119 . 2 . Krahn A, Klein GJ, Yee R, Skanes AC. Randomized assessment of syncope trial. Conventional diagnostic testing versus a prolonged monitoring strategy. Circulation 2001;104:46-51
Examples of ECG recordings obtained by the Reveal® ILR system in 2 symptomatic patients. See associated text for details .
Results of the initial phase of RAST are summarized here. Among patients randomized to ILR, there appeared to be greater diagnostic yield than in patients randomized to the conventional diagnostic pathway .
In RAST, patients who remained undiagnosed after completion of the first arm of the study (see preceding slide) were offered crossover to the other diagnostic strategy arm. Once again, ILR proved superior to the conventional diagnostic strategy
Results show patients implanted with the ILR are more likely to receive a diagnosis in any category . The ILR was almost 5 times better at detecting bradycardia compared to conventional testing . Reference Krahn A, Klein GJ, Yee R, Skanes AC. Randomized assessment of syncope trial. Conventional diagnostic testing versus a prolonged monitoring strategy. Circulation 2001;104:46-51
Diagnosing VVS VVS is most effectively diagnosed if the detailed medical history is ‘classic’. However, this is not often the case, and supporting evidence is needed, Such supportive evidence may include : Patient history, physical examination, ECG, and other tests provide no diagnosis for patient complaints of syncope . Patient experiences syncope during head-up tilt table testing. Test completion without syncope is a negative result . The following HUT protocol is based on the ACC Consensus Document on tilt table testing (Benditt 1996). Other accepted HUT protocols do exist . Overnight fast, morning test ECG (at least 3 leads ) Continuous blood pressure monitoring Patient remains supine on the table for 15-30 minutes . Tilt to 60-80 degrees for 20-45 minutes . Lower to horizontal and administer isoproterenol at 1-5 g/min until heart rate increases 25% . Re-tilt for 10 minutes REFERENCE : Benditt DG, Ferguson DW, Grubb BP, et al. Tilt table testing for syncope. ACC Expert Consensus Document. JACC. 1996;28(1):263-275 .
A yield is defined as information that will point to more finely focused tests, specialties, or treatments . Patient history and physical exam are the most productive diagnostic tools for recurrent syncope, accounting for 49-85% of all syncope diagnoses. 1,2 An ECG, also considered a first-line test, is diagnostic in 2-11% of cases. 2 Beyond that, other tests have variable diagnostic yields. Holter monitors (worn for 1-3 days) capture ECGs during a syncopal episode in only 1% of patients, based on a mean time to recurrent event of 5.1 months. 7 The effectiveness of tilt table tests, a common tool used to identify vasovagal syncope, depends on several factors, including patient selection and use of provocative drugs. Depending on these factors, the rate of positive tests has been reported in the range of 11-87%. 3,5 However, about 10% or more of the population (who do not experience syncope) will have positive tilt table tests. 4,6 External loop recorders (worn for 2-3 weeks) are most productive in motivated patients who experience relatively frequent syncope. They provide a diagnostic yield of 20%. 7 Electrophysiology (EP) studies are generally more productive in patients with structural heart disease (SHD) and therefore are generally a higher priority for patients in this group. 1 EP studies are used to diagnose syncope by inducing symptoms under controlled conditions, thereby attaining a “presumptive” diagnosis. 1 EP testing usually fails to identify intermittent bradycardia as a cause of syncope (6%) and may sometimes reveal unrelated rhythm disturbances that may be mistakenly identified as the cause of syncope. 2 1 . Kapoor W, et al. A prospective evaluation and follow-up of patients with syncope. N Engl J Med 1983;309:197-204 . 2 . Kapoor W. Diagnostic evaluation of syncope. Amer J Med 1991;90:91-106 . 3 . Linzer M, et al. Clinical guideline: Diagnosing syncope: Part 2: Unexplained syncope. Ann Intern Med 1997;127:76-86 . 4 . Kapoor W. Evaluation and outcome of patients with syncope. Medicine 1990;69:160-175 . 5 . Kapoor W. Evaluation and management of the patient with syncope. JAMA 1992;268:2553-2560 . 6 . Krahn A, et al. The etiology of syncope in patients with negative tilt table and electrophysiological testing. Circulation 1995;92:1819-1824 . Krahn A, Klein G, Yee R: Recurrent syncope. Experience with an implantable loop recorder. Cardiology Clinics 1997; 15(2):313-326 . 8 . Eagle K,, et al. The Yale J Biol and Medicine. 1983; 56: 1-8 . 9 . Day S, et al. Am J Med. 1982; 73: 15-23 . 10 . Stetson P, et al. PACE. 1999; 22 (part II): 782 . Please also see : Brignole M, Alboni P, Benditt DG, et al. “Guidelines on Management (Diagnosis and Treatment) of Syncope. Eur Heart Journal 2001; 22: 1256-1306 .